Literature DB >> 6345355

Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions.

B Folkow, G F Di Bona, P Hjemdahl, P H Torén, B G Wallin.   

Abstract

The relationship between plasma levels of norepinephrine (NE) and sympathetic neural activity is discussed with special reference to human primary hypertension. Since sympathetic discharge is differentiated, neural activity to a given target organ will contribute variably to plasma NE levels in different situations. Hemodynamically, early primary hypertension is often characterized by a mild defense reaction-like pattern with signs of increased sympathetic activity to the heart and vasoconstriction in the renal and splanchnic vascular beds. Although important hemodynamically, these organs seem to be of less importance as contributors to peripheral plasma NE levels. In contrast, muscle sympathetic activity and muscle vascular resistance is unchanged or reduced. Since this organ mass contributes importantly to plasma NE levels, especially in peripheral venous blood, it is not surprising that most patients with primary hypertension have normal NE levels. It is concluded that NE concentrations in forearm or mixed venous blood are unreliable indicators of sympathetic neural contributions to essential hypertension, tending to underestimate this element, and that regional measurements of NE overflow are needed for a reliable analysis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345355     DOI: 10.1161/01.hyp.5.4.399

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  27 in total

Review 1.  Sympathetic nervous system function in fibromyalgia.

Authors:  F Petzke; D J Clauw
Journal:  Curr Rheumatol Rep       Date:  2000-04       Impact factor: 4.592

2.  Effects of mental and physical stress on plasma catecholamine levels before and after beta-adrenoceptor blocker treatment.

Authors:  E Paran; L Neumann; N Cristal
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

3.  The sympathetic response to euglycaemic hyperinsulinaemia. Evidence from microelectrode nerve recordings in healthy subjects.

Authors:  C Berne; J Fagius; T Pollare; P Hjemdahl
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

Review 4.  The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.

Authors:  E S Domurat; A N Elias
Journal:  J Natl Med Assoc       Date:  1992-02       Impact factor: 1.798

Review 5.  Assessment of sympathetic cardiovascular influences in man: haemodynamic and humoral markers versus microneurography.

Authors:  G Mancia; G Grassi
Journal:  Clin Auton Res       Date:  1991-09       Impact factor: 4.435

Review 6.  Muscle sympathetic nerve activity during exercise.

Authors:  Keisho Katayama; Mitsuru Saito
Journal:  J Physiol Sci       Date:  2019-05-03       Impact factor: 2.781

7.  Measurement of regional neuronal removal of norepinephrine in man.

Authors:  D S Goldstein; R Zimlichman; R Stull; J Folio; P D Levinson; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

8.  Simultaneous determination of plasma noradrenaline and adrenaline kinetics. Responses to nitroprusside-induced hypotension and 2-deoxyglucose-induced glucopenia in the rabbit.

Authors:  O S Medvedev; M D Esler; J A Angus; H S Cox; G Eisenhofer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

9.  Glucose tolerance in hypertensive patients during treatment with the calcium antagonist, felodipine.

Authors:  T Hedner; D Elmfeldt; H Von Schenck; E Sjögren; U Smith
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

10.  A comparison of sympathoadrenal activity and cardiac performance at rest and during exercise in patients with ventricular demand or atrial synchronous pacing.

Authors:  S K Pehrsson; P Hjemdahl; R Nordlander; H Aström
Journal:  Br Heart J       Date:  1988-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.